Cancer Research Institute News

Recognising a champion for higher education, UniSA to dedicate the Bradley Building

The University of South Australia Council has voted unanimously to honour the life and contribution of former Vice Chancellor, Emeritus Professor Denise...

New study reveals why flu can be devastating for pregnant women

Decoding the genetics that drive disease

From Alzheimer’s to obesity, life can change dramatically if you discover you have a genetic risk of disease. Now, a new study from the Australian Centre for...

Endometriosis: no cure, but diagnosis could avert surgery

A UniSA researcher is exploring alternative diagnosis for women with deep infiltrating endometriosis, a painful condition which often takes years to diagnose.

Genetic discovery delivers new hope for aggressive breast cancers

Groundbreaking cancer research by the University of South Australia has identified an invasive protein molecule that could be responsible for some of the most...

Different approach needed to ‘buy time’ and tackle COVID-19

A prominent Australian pharmacologist has called for a new approach to treating COVID-19 as hopes fade of finding an effective vaccine or antiviral before the...

Whole body scans for trauma patients cut time spent in emergency departments

Ever sat in an ambulance or crowded emergency room with a loved one who has sustained serious injuries, waiting for a scan as precious life-saving minutes tick...

New research shows child abuse and neglect results in increased hospitalisations in childhood and beyond

In a new UniSA study published in the leading international journal, Child Abuse and Neglect, UniSA researchers have found that by their mid-teens, children...

Researchers pioneer early diagnostic tool for Parkinson’s disease

University of South Australia researchers are pioneering a new method to more accurately diagnose Parkinson’s disease, a neurodegenerative brain disorder which...

Breakthrough discovery to transform prostate cancer treatment

A novel formulation of the prostate cancer drug abiraterone acetate – currently marketed as Zytiga - will dramatically improve the quality of life for people...